Epidemiology of Nonsteroidal Anti-Inflammatory Drugs and Colorectal Cancer

[1]  L. G. García Rodríguez,et al.  Reduced Risk of Colorectal Cancer among Long-Term Users of Aspirin and Nonaspirin Nonsteroidal Antiinflammatory Drugs , 2001, Epidemiology.

[2]  D. Alberts,et al.  Effects of piroxicam on prostaglandin E2 levels in rectal mucosa of adenomatous polyp patients: a randomized phase IIb trial. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[3]  H. Sheng,et al.  Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models. , 2000, Cancer research.

[4]  K. Seibert,et al.  The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. , 2000, Cancer research.

[5]  B. Levin,et al.  The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. , 2000, The New England journal of medicine.

[6]  V. Steele,et al.  Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. , 2000, Cancer research.

[7]  E. Levin,et al.  Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing , 1999, Nature Medicine.

[8]  V. Steele,et al.  Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process. , 1999, Cancer research.

[9]  C. J. Barnes,et al.  Determination of an optimal dosing regimen for aspirin chemoprevention of 1,2-dimethylhydrazine-induced colon tumours in rats , 1999, British Journal of Cancer.

[10]  V. Steele,et al.  Prevention by aspirin and its combination with alpha-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colon. , 1999, Carcinogenesis.

[11]  W. Ray,et al.  Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study. , 1999, Archives of internal medicine.

[12]  R. Kucherlapati,et al.  Genotype-phenotype correlation in murine Apc mutation: differences in enterocyte migration and response to sulindac. , 1999, Cancer research.

[13]  M. Taketo.  Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). , 1998, Journal of the National Cancer Institute.

[14]  I. Blair,et al.  Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithine. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  M. Bertagnolli,et al.  Aspirin prevents tumors in a murine model of familial adenomatous polyposis. , 1998, Surgery.

[16]  R. DuBois,et al.  Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells , 1998, Cell.

[17]  K. Seibert,et al.  Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. , 1998, Cancer research.

[18]  C. Paraskeva,et al.  Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  M. Mcentee,et al.  Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis. , 1997, Cancer research.

[20]  K. Schmid,et al.  Clinical and genomic influence of sulindac on rectal mucosa in familial adenomatous polyposis , 1997, Diseases of the colon and rectum.

[21]  C. Rock,et al.  Suppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin dose. , 1997, Journal of the National Cancer Institute.

[22]  D. Alberts,et al.  Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. , 1997, Cancer research.

[23]  V. Steele,et al.  Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. , 1997, Cancer research.

[24]  Y. Yazaki,et al.  Effects of sulindac on sporadic colorectal adenomatous polyps. , 1997, Gut.

[25]  William L. Smith,et al.  Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2* , 1996, The Journal of Biological Chemistry.

[26]  E. Pukkala,et al.  Low incidence of colorectal cancer in patients with rheumatoid arthritis. , 1996, Clinical and experimental rheumatology.

[27]  K. Kinzler,et al.  Apoptosis and APC in colorectal tumorigenesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Bertagnolli,et al.  Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. , 1996, Cancer research.

[29]  F. Giardiello.  NSAID-induced polyp regression in familial adenomatous polyposis patients. , 1996, Gastroenterology clinics of North America.

[30]  D. Hicks,et al.  Differential Growth Inhibition by the Aspirin Metabolite Salicylate in Human Colorectal Tumor Cell Lines: Enhanced Apoptosis in Carcinoma and in Vitro-transformed Adenoma Relative to Adenoma Cell Lines , 1996 .

[31]  V. Steele,et al.  Piroxicam-induced regression of azoxymethane-induced aberrant crypt foci and prevention of colon cancer in rats. , 1996, Carcinogenesis.

[32]  H. Buhr,et al.  [Desmoid tumors in patients with familial adenomatous polyposis (FAP). Clinical and therapeutic observations from the Heidelberg polyposis register]. , 1995, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

[33]  W C Willett,et al.  Aspirin and the risk of colorectal cancer in women. , 1995, The New England journal of medicine.

[34]  P. Pasricha,et al.  The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. , 1995, Gastroenterology.

[35]  K. Schmid,et al.  Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment , 1995, Diseases of the colon and rectum.

[36]  J. Balibrea,et al.  [Treatment with sulindac of adenomatous polyps in familial polyposis]. , 1995, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[37]  A. Spigelman,et al.  Effect of sulindac on small polyps in familial adenomatous polyposis , 1995, The Lancet.

[38]  P. Lavori,et al.  Effect of sulindac on sporadic colonic polyps. , 1995, Gastroenterology.

[39]  E. Rimm,et al.  Alcohol, low-methionine--low-folate diets, and risk of colon cancer in men. , 1995, Journal of the National Cancer Institute.

[40]  H. Lynch,et al.  Rectal cancer after prolonged sulindac chemoprevention. A case report , 1995, Cancer.

[41]  M. Wargovich,et al.  Inhibition of aberrant crypt growth by non‐steroidal anti‐inflammatory agents and differentiation agents in the rat colon , 1995, International journal of cancer.

[42]  W C Willett,et al.  Dietary factors and risk of colon cancer. , 1994, Annals of medicine.

[43]  R. Coffey,et al.  Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. , 1994, Gastroenterology.

[44]  E. Rimm,et al.  Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals , 1994, Annals of Internal Medicine.

[45]  H. Adami,et al.  Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. , 1994, Gastroenterology.

[46]  A. Davis,et al.  Aspirin reduces the incidence of colonic carcinoma in the dimethylhydrazine rat animal model. , 1994, Australian and New Zealand journal of medicine.

[47]  P. Dolara,et al.  Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment. , 1994, Gastroenterology.

[48]  M. Ghia,et al.  Effect of aspirin on incidence and growth of aberrant crypt foci induced in the rat colon by 1,2-dimethylhydrazine. , 1994, Cancer letters.

[49]  C. Williams,et al.  Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis , 1993, The British journal of surgery.

[50]  B. Rigas,et al.  Altered eicosanoid levels in human colon cancer. , 1993, The Journal of laboratory and clinical medicine.

[51]  G. Kelloff,et al.  Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. , 1993, Carcinogenesis.

[52]  S. Piantadosi,et al.  Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. , 1993, The New England journal of medicine.

[53]  M. Thun,et al.  Aspirin use and risk of fatal cancer. , 1993, Cancer research.

[54]  G. Winde,et al.  The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration , 1993, International Journal of Colorectal Disease.

[55]  J. F. Fraumeni,et al.  Incidence of cancer among patients with rheumatoid arthritis. , 1993, Journal of the National Cancer Institute.

[56]  L. Marnett.  Aspirin and the potential role of prostaglandins in colon cancer. , 1992, Cancer research.

[57]  G. Kelloff,et al.  Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds. , 1992, Carcinogenesis.

[58]  F. DeRubertis,et al.  Effects of aspirin on 1,2-dimethylhydrazine-induced colonic carcinogenesis. , 1992, Carcinogenesis.

[59]  J. Bordas,et al.  Effects of long-term sulindac therapy on colonic polyposis. , 1991, Annals of internal medicine.

[60]  M. Thun,et al.  Aspirin use and reduced risk of fatal colon cancer. , 1991, The New England journal of medicine.

[61]  P. Vielh,et al.  Sulindac causes regression of rectal polyps in familial adenomatous polyposis. , 1991, Gastroenterology.

[62]  S. Skinner,et al.  Sulindac inhibits the rate of growth and appearance of colon tumors in the rat. , 1991, Archives of surgery.

[63]  G. Kelloff,et al.  Chemoprevention of Colon Carcinogenesis by Dietary Administration of Piroxicam, α-Difluoromethylornithine, 16α-Fluoro-5-androsten-17-one, and Ellagic Acid Individually and in Combination , 1991 .

[64]  B. Henderson,et al.  Aspirin use and incidence of large-bowel cancer in a California retirement community. , 1991, Journal of the National Cancer Institute.

[65]  S. Shapiro,et al.  A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. , 1991, Journal of the National Cancer Institute.

[66]  H. Kusaka,et al.  Relationship between blood plasma prostaglandin E2 and liver and lung metastases in colorectal cancer , 1990, Diseases of the colon and rectum.

[67]  Friend Wg.  Sulindac suppression of colorectal polyps in Gardner's syndrome. , 1990 .

[68]  M. Pollard,et al.  Prevention and treatment of primary intestinal tumors in rats by piroxicam. , 1989, Cancer research.

[69]  B. Henderson,et al.  Aspirin use and chronic diseases: a cohort study of the elderly. , 1989, BMJ.

[70]  D. Appleton,et al.  A protective effect of sulindac against chemically‐induced primary colonic tumours in mice , 1988, The Journal of pathology.

[71]  M. Boyd,et al.  Profiles of prostaglandin biosynthesis in sixteen established cell lines derived from human lung, colon, prostate, and ovarian tumors. , 1988, Cancer research.

[72]  G. Kelloff,et al.  Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development. , 1987, Cancer research.

[73]  A. Bennett,et al.  Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues. , 1987, Gut.

[74]  A. Bull,et al.  Inhibition of intestinal carcinogenesis in rats: effect of difluoromethylornithine with piroxicam or fish oil. , 1986, Journal of the National Cancer Institute.

[75]  M. Laakso,et al.  Cancer mortality in patients with rheumatoid arthritis. , 1986, The Journal of rheumatology.

[76]  Silvestre Carneiro,et al.  SULINDAC TREATMENT FOR FAMILIAL POLYPOSIS COLI , 1985, The Lancet.

[77]  M. Pollard,et al.  Effect of piroxicam on primary intestinal tumors induced in rats by N-methylnitrosourea. , 1984, Cancer letters.

[78]  U. Metzger,et al.  Influence of various prostaglandin synthesis inhibitors on DMH-induced rat colon cancer , 1984, Diseases of the colon and rectum.

[79]  Morris Pollard,et al.  The suppressive effect of piroxicam on autochthonous intestinal tumors in the rat. , 1983, Cancer letters.

[80]  T. Narisawa,et al.  Inhibition of initiation and promotion by N-methylnitrosourea-induced colon carcinogenesis in rats by non-steroid anti-inflammatory agent indomethacin. , 1983, Carcinogenesis.

[81]  W. Waddell,et al.  Sulindac for polyposis of the colon , 1983, Journal of surgical oncology.

[82]  Morris Pollard,et al.  Prolonged antitumor effect of indomethacin on autochthonous intestinal tumors in rats. , 1983, Journal of the National Cancer Institute.

[83]  T. Narisawa,et al.  Inhibition of development of methylnitrosourea-induced rat colonic tumors by peroral administration of indomethacin. , 1982, Gan.

[84]  M. Pollard,et al.  Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine. , 1981, Science.

[85]  Morris Pollard,et al.  Treatment of Chemically-Induced Intestinal Cancers with Indomethacin 1 , 1981, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[86]  T. Kudo,et al.  Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment. , 1981, Cancer research.

[87]  T. Narisawa,et al.  Antitumor activity of indomethacin on methylazoxymethanol-induced large bowel tumors in rats. , 1980, Gan.

[88]  Morris Pollard,et al.  Induction of colon tumors in 1,2-dimethylhydrazine-resistant Lobund Wistar rats by methylazoxymethanol acetate. , 1978, Journal of the National Cancer Institute.

[89]  T. Żebro,et al.  Prostaglandins from tumours of human large bowel. , 1977, British Journal of Cancer.

[90]  Cove-Smith,et al.  Proceedings: Prostaglandins in human colonic carcinoma. , 1975 .

[91]  B. Jaffe,et al.  Prostaglandins and cancer: an update. , 1974, Prostaglandins.

[92]  T. Sugimura,et al.  Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2 , 2005, Journal of Cancer Research and Clinical Oncology.

[93]  T. Narisawa,et al.  Reduction of carcinogenicity of N-nitrosomethylurea by indomethacin and failure of resuming effect of prostaglandin E2 (PGE2) against indomethacin , 2004, Journal of Cancer Research and Clinical Oncology.

[94]  Taylor Murray,et al.  Cancer Statistics, 2001 , 2001, CA: a cancer journal for clinicians.

[95]  G. Piazza,et al.  Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis. , 1999, Advances in experimental medicine and biology.

[96]  J. Mäkelä,et al.  Sulindac therapy for familial adenomatous polyposis after colectomy and ileorectal anastomosis. , 1994, Annales chirurgiae et gynaecologiae.

[97]  Jayashree,et al.  Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet. , 1990, Cancer research.

[98]  D. Appleton,et al.  The effect of sulindac on colonic tumour formation in dimethylhydrazine-treated mice. , 1990, Acta histochemica. Supplementband.

[99]  P. Burtin,et al.  [Rectal micropolyps after total colectomy in familial polyposis. Efficacy of sulindac]. , 1990, Gastroenterologie clinique et biologique.

[100]  E. Cerise,et al.  Sulindac for polyposis of the colon. , 1989, American journal of surgery.

[101]  G. Stemmermann,et al.  Aspirin and colonic epithelium. , 1989, Gastroenterology.

[102]  B. Levin,et al.  Frontiers in gastrointestinal cancer , 1984 .

[103]  Morris Pollard,et al.  Indomethacin treatment of rats with dimethylhydrazine-induced intestinal tumors. , 1980, Cancer treatment reports.

[104]  T. Hakulinen,et al.  Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. , 1978, Journal of chronic diseases.

[105]  V. Steele,et al.  Chemoprevention of Colon Carcinogenesis by Sulindac , a Nonsteroidal Anti-inflammatory Agent 1 , 2022 .